Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042)

• Status: Completed
• Trial end date: 2008-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will demonstrate the definitive bioequivalence of a solid dose formulation of MK0974 to the liquid filled capsule formulation of MK0974.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.

Criteria

Inclusion Criteria:

• Subject is in good health

• Subject is a nonsmoker

• Subject is willing to comply with the study restrictions

Exclusion Criteria:

• Subject has history of stroke, chronic seizures, or any major neurological disorder

• Subject has a history of cancer

• Subject is a nursing mother

• Subject has uncontrolled high blood pressure

• Subject has or has a history of any disease or condition that might made participation in the study unsafe or confound the study results